Envestnet Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
94,872
-829
| -0.9% | -$9.6K | ﹤0.01% | 3232 |
|
|
2025
Q1 | $835K | Buy |
95,701
+12,136
| +15% | +$106K | ﹤0.01% | 3316 |
|
|
2024
Q4 | $1.2M | Sell |
83,565
-22,189
| -21% | -$319K | ﹤0.01% | 3042 |
|
|
2024
Q3 | $2.39M | Buy |
105,754
+49,111
| +87% | +$1.11M | ﹤0.01% | 2536 |
|
|
2024
Q2 | $1.1M | Buy |
56,643
+13,449
| +31% | +$262K | ﹤0.01% | 2968 |
|
|
2024
Q1 | $1.62M | Buy |
43,194
+21,099
| +95% | +$792K | ﹤0.01% | 2704 |
|
|
2023
Q4 | $1.24M | Buy |
22,095
+9,335
| +73% | +$522K | ﹤0.01% | 2782 |
|
|
2023
Q3 | $526K | Buy |
12,760
+5,860
| +85% | +$242K | ﹤0.01% | 3220 |
|
|
2023
Q2 | $385K | Sell |
6,900
-157
| -2% | -$8.77K | ﹤0.01% | 3355 |
|
|
2023
Q1 | $394K | Sell |
7,057
-5,630
| -44% | -$314K | ﹤0.01% | 3305 |
|
|
2022
Q4 | $462K | Sell |
12,687
-582
| -4% | -$21.2K | ﹤0.01% | 3134 |
|
|
2022
Q3 | $378K | Sell |
13,269
-2,461
| -16% | -$70.1K | ﹤0.01% | 3213 |
|
|
2022
Q2 | $712K | Buy |
15,730
+1,866
| +13% | +$84.5K | ﹤0.01% | 2847 |
|
|
2022
Q1 | $1.06M | Sell |
13,864
-1,267
| -8% | -$96.4K | ﹤0.01% | 2620 |
|
|
2021
Q4 | $2.25M | Buy |
15,131
+4,510
| +42% | +$672K | ﹤0.01% | 2084 |
|
|
2021
Q3 | $1.55M | Buy |
10,621
+4,623
| +77% | +$673K | ﹤0.01% | 2260 |
|
|
2021
Q2 | $1.18M | Buy |
5,998
+2,106
| +54% | +$413K | ﹤0.01% | 2409 |
|
|
2021
Q1 | $704K | Buy |
3,892
+740
| +23% | +$134K | ﹤0.01% | 2645 |
|
|
2020
Q4 | $446K | Buy |
3,152
+1,255
| +66% | +$178K | ﹤0.01% | 2717 |
|
|
2020
Q3 | $237K | Buy |
+1,897
| New | +$237K | ﹤0.01% | 2831 |
|